Loading clinical trials...
Loading clinical trials...
Genomic Predictors of Decitabine Response in AML/MDS
Conditions
Interventions
decitabine
Locations
1
United States
Washington University School of Medicine
St Louis, Missouri, United States
Start Date
February 12, 2013
Primary Completion Date
June 23, 2017
Completion Date
November 13, 2017
Last Updated
October 2, 2018
NCT06852222
NCT07270978
NCT05292664
NCT06499285
NCT04953910
NCT04953897
Lead Sponsor
Washington University School of Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions